Oak Associates’s Telix Pharmaceuticals TLX Stock Holding History
Bought
Maintained
Sold
Other funds holding TLX
Oak Associates's TLX Position: Q3 2026 in Review
Oak Associates opened a new position in Telix Pharmaceuticals (TLX) in Q3 2026: 12,244 shares worth $134K. The stake represents 0.01% of the portfolio and ranks #144 among its holdings.
74 funds tracked by Wall St. Rank hold TLX as of Q3 2026.
- Oak Associates held 12,244 shares of Telix Pharmaceuticals worth $134K as of Q3 2026.
- Telix Pharmaceuticals was a new Oak Associates position in Q3 2026.
- Telix Pharmaceuticals made up 0.01% of Oak Associates's portfolio in Q3 2026, its #144 holding.
- 74 funds tracked by Wall St. Rank held Telix Pharmaceuticals as of Q3 2026.
Based on Oak Associates's 13F filing for Q3 2026, filed 16 Nov 2026.